|Bid||2.11 x 900|
|Ask||2.14 x 3000|
|Day's Range||2.10 - 2.22|
|52 Week Range||1.65 - 4.69|
|PE Ratio (TTM)||-1.60|
|Earnings Date||Nov 13, 2017 - Nov 17, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||5.00|
On a per-share basis, the San Diego-based company said it had net income of 6 cents. The pharmaceutical and drug compounding company posted revenue of $6.9 million in the period. In the final minutes of ...
SAN DIEGO , Aug. 10, 2017 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today reported financial results for the second quarter 2017. ...
NEW YORK, NY / ACCESSWIRE / August 10, 2017 / Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 10, 2017 ...